التفاصيل البيبلوغرافية
| العنوان: |
A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients. |
| المؤلفون: |
de Mazancourt, Philippe, Quélin, Florence, Flaujac, Claire, de Raucourt, Emmanuelle, Guillet, Benoît, Bauduer, Frédéric, Ernest, Vincent, Beurrier, Philippe, Avril, Aurélie, d'Oiron, Roseline, Biron‐Andréani, Christine, Meunier, Sandrine, Dargaud, Yesim |
| المصدر: |
Haemophilia; Jul2023, Vol. 29 Issue 4, p1113-1120, 8p, 2 Diagrams, 1 Graph |
| مصطلحات موضوعية: |
GENETIC variation, QUALITY control, HOMODIMERS, BLOOD coagulants, POLYPEPTIDES |
| مستخلص: |
Introduction: Dominant‐negative effects have been described for 10 F11 variants in the literature. Aim: The current study aimed at identifying putative dominant‐negative F11 variants. Material and methods: This research consisted in a retrospective analysis of routine laboratory data. Results: In a series of 170 patients with moderate/mild factor XI (FXI) deficiencies, we identified heterozygous carriers of previously reported dominant‐negative variants (p.Ser243Phe, p.Cys416Tyr, and p.Gly418Val) with FXI activities inconsistent with a dominant‐negative effect. Our findings also do not support a dominant‐negative effect of p.Gly418Ala. We also identified a set of patients carrying heterozygous variants, among which five out of 11 are novel, with FXI activities suggesting a dominant‐negative effect (p.His53Tyr, p.Cys110Gly, p.Cys140Tyr, p.Glu245Lys, p.Trp246Cys, p.Glu315Lys, p.Ile421Thr, p.Trp425Cys, p.Glu565Lys, p.Thr593Met, and p.Trp617Ter). However, for all but two of these variants, individuals with close to half normal FXI coagulant activity (FXI:C) were identified, indicating an inconstant dominant effect. Conclusion: Our data show that for some F11 variants recognized has having dominant‐negative effects, such effects actually do not occur in many individuals. The present data suggest that for these patients, the intracellular quality control mechanisms eliminate the variant monomeric polypeptide before homodimer assembly, thereby allowing only the wild‐type homodimer to assemble and resulting in half normal activities. In contrast, in patients with markedly decreased activities, some mutant polypeptides might escape this first quality control. In turn, assembly of heterodimeric molecules as well as mutant homodimers would result in activities closer to 1:4 of FXI:C normal range. [ABSTRACT FROM AUTHOR] |
|
Copyright of Haemophilia is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder